Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 33, which means every article in Journal of Stem Cell Research & Therapy has got 33 average citations.
Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Year wise published articles |
58 | 59 | 65 | 23 | 13 |
Year wise citations received |
646 | 734 | 808 | 672 | 601 |
Journal total citations count | 6448 |
Journal Impact Factor | 1.64 |
Journal 5 years Impact Factor | 1.70 |
Journal CiteScore | 11.56 |
Journal h-index | 33 |
p53 and Cell Fate: Sensitizing Head and Neck Cancer Stem Cells to Chemotherapy
p53 and Cell Fate: Sensitizing Head and Neck Cancer Stem Cells to Chemotherapy
BAR-Seq clonal tracking of gene-edited cells
Ready for repair? Gene editing enters the clinic for the treatment of human disease.
Assessment of Three-Drug Combination Pharmacodynamic Interactions in Pancreatic Cancer Cells
Emerging concepts in vector development for glial gene therapy: Implications for leukodystrophies
Extracellular Vesicles as Drug Delivery Systems in Cancer
Applications of genome editing technology in animal disease modeling and gene therapy
A Similar Speciation Process Relying on Cellular Stochasticity in Microbial and Cancer Cell Populations
Transhumanist Genetic Enhancement: Creation of a 'New Man'Through Technological Innovation
Gene therapy for severe combined immunodeficiencies and beyond
Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development
Linkage between EMT and stemness state through molecular association between TWIST1 and NY-ESO1 in esophageal squamous cell carcinoma
Pinostrobin inhibits proliferation and induces apoptosis in cancer stem-like cells through a reactive oxygen species-dependent mechanism
Rare opportunities: CRISPR/Cas-based therapy development for rare genetic diseases
Stroma secreted IL6 selects for “stem-like” population and alters pancreatic tumor microenvironment by reprogramming metabolic pathways
Targeted gene delivery: where to land
Therapy Resistance, Cancer Stem Cells and ECM in Cancer: The Matrix Reloaded
Therapeutic gene editing in haematological disorders with CRISPR/Cas9
Modeling breast cancer progression to bone: how driver mutation order and metabolism matter